Skip to content
10-Q

Quarterly Report

AMERICAN BIO MEDICA CORPORATION

0001654954-22-006952

← back to feed
Filed
May 16, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 16, 2022 48.1M sh
Short Term Debt Q1 2022 · Mar 31, 2022 $1.24M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $17K
Cash And Equivalents Q1 2022 · Dec 31, 2021 $115K
Cash And Equivalents Q1 2022 · Mar 31, 2021 $63K
Cash And Equivalents Q1 2022 · Dec 31, 2020 $98K
Current Liabilities Q1 2022 · Mar 31, 2022 $2.87M
Current Liabilities Q1 2022 · Dec 31, 2021 $2.82M
Total Liabilities Q1 2022 · Mar 31, 2022 $2.87M
Total Liabilities Q1 2022 · Dec 31, 2021 $2.83M
Current Assets Q1 2022 · Mar 31, 2022 $1.04M
Current Assets Q1 2022 · Dec 31, 2021 $1.34M
Total Assets Q1 2022 · Mar 31, 2022 $1.57M
Total Assets Q1 2022 · Dec 31, 2021 $1.88M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$359K
Stockholders Equity Q1 2022 · Mar 31, 2021 −$1.43M
Stockholders Equity Q1 2022 · Dec 31, 2020 −$1.26M
Sga Expense Q1 2022 · Mar 31, 2021 $511K
Rd Expense Q1 2022 · Mar 31, 2021 $20K
Net Income Q1 2022 · Mar 31, 2021 −$556K
Operating Income Q1 2022 · Mar 31, 2021 −$509K
Gross Profit Q1 2022 · Mar 31, 2021 $105K
Cost Of Revenue Q1 2022 · Mar 31, 2021 $461K
Revenue Q1 2022 · Mar 31, 2021 $566K